iBio, Inc. (IBIO) Announces No Opposition on Bio-Defense Product Patent in Europe Following Expiration
Tweet Send to a Friend
iBio, Inc. (NYSE: IBIO) announced it received notice from the European Patent Office that the opposition period expired for a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
